Bioelectronics Corp (BIEL)

[srinsocal]

As in my NASA post, where it is not the sales to astronauts it is the publicity of having NASA considering the use of ActiPatch on long distance missions that is the value.

Dr. Ifeld's interest in RecoveryRx at UCSD, a Top 10 US Research University, the immediate benefit is the exposure BIEL gets in the research community. Thousands of researchers and related medical professionals exposed to the drug free pain relief RecoveryRx provides.


Sunday, January 01, 2023 post 305183
NASA Conclusions:

5.3 Conclusions
The information obtained in the execution of this review effort leads to 2 recommendations for forward work:

1. Tie into DoD and NIH research funding efforts to improve pain treatment: the NIH has a
federal partners workgroup for their HEAL Initiative that could conceivably be joined by
NASA, and the DoD CPMRP’s initial solicitation only recently completed so that program is
young and potentially synergies could be identified with NASA.

2. Obtain an ActiPatch device for evaluation and determine whether it could be beneficial and adapted to spaceflight use. (page 16)

https://ntrs.nasa.gov/api/citations/20205008893/downloads/2020ICA_Mullenax_report_24Sep20.pdf